Lukasik, Maria <br/><br/>
Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.  [electronic resource] 

 -  Thrombosis and haemostasis  Feb 2012 
 - 346-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2567-689X 
<br/><br/><label>Standard No.: </label>10.1160/TH11-05-0345  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers--metabolism<br/>Blood Platelets--immunology<br/>CD40 Ligand--genetics<br/>Cell Aggregation<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Inflammation Mediators--metabolism<br/>Male<br/>Middle Aged<br/>Monocytes--immunology<br/>P-Selectin--metabolism<br/>Predictive Value of Tests<br/>Prognosis<br/>Prospective Studies<br/>Stroke--diagnosis<br/>Survival Analysis<br/>Up-Regulation